Biogen· @biogen · X·· 2026-06-18AI 评分22
AI 导读
在 @ATCMeeting 上，我们正在分享一款靶向 CD-38 细胞、用于抗体介导排斥的在研疗法的新数据。欢迎参加，了解我们在肾移植领域的持续研究以及我们的后期临床试验。了解更多：http://ow.ly/MNtN50ZcR2t
正文
At the @ATCMeeting, we're sharing new data on our investigational therapy designed to target CD-38 cells in antibody-mediated rejection. Join us to learn about our ongoing research in kidney transplantation and our late-stage clinical trials. Learn more: http://ow.ly/MNtN50ZcR2t
来源：Biogen · x.com